[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
M
M
Iwamoto
T
T
Kumada
T
T
Hara
Y
Y
Abiko
H
H
Ogawa
M
M
Tomikawa
D000208:Acute Disease; D000818:Animals; D020152:Antithrombin III Deficiency; D000991:Antithrombins / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D001157:Arterial Occlusive Diseases / Q000517:prevention & control*; D051379:Mice; D010875:Pipecolic Acids / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000517:prevention & control*; D051381:Rats; D011919:Rats, Inbred Strains; D013449:Sulfonamides; D013927:Thrombosis / Q000517:prevention & control*; D014682:Vena Cava, Inferior
D000991:Antithrombins; D010875:Pipecolic Acids; D013449:Sulfonamides; D001120:Arginine; C031942:argatroban